Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 047676/0690 | |
| Pages: | 5 |
| | Recorded: | 12/05/2018 | | |
| Attorney Dkt #: | 102938-US-CNT[6] |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
|
Issue Dt:
|
09/15/2020
|
Application #:
|
16117020
|
Filing Dt:
|
08/30/2018
|
|
Publication #:
|
|
Pub Dt:
|
04/04/2019
| | | | |
|
Title:
|
USE OF MYELOPEROXIDASE (MPO) INHIBITORS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF TO TREAT MULTIPLE SYSTEM ATROPHY (MSA) 938
|
|
|
Assignee
|
|
|
|
|
| SE-151 85 |
| SODERTALJE, SWEDEN |
|
|
Correspondence name and address
|
| |
ASTRAZENECA MEDIMMUNE
|
| |
ONE MEDIMMUNE WAY
|
| |
GAITHERSBURG, MD 20878
|
Search Results as of:
06/23/2024 01:56 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
